The global spinal cord stimulators market is on a robust growth trajectory, poised to reach an impressive valuation of USD 5,441.4 million by 2033. Currently valued at USD 2,702.7 million in 2023, the ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

During the study period, 400 patients were implanted with SCS devices. In this group, 37% of patients received devices from Boston Scientific, 27.5% from Medtronic, 22.5% from Nevro, 11.8% from ...

The Affera mapping and ablation system with the Sphere-9 catheter [Images courtesy of Medtronic] Medtronic (NYSE:MDT) today said it received FDA approval for its Affera mapping and ablation system ...

24, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug Administration (FDA) approval of the Affera™ Mapping and ...

In 2003, he underwent implantation of a SCS (Itrel III Model 7425, Medtronic Inc., Minneapolis, MN, USA) connected to a quadripolar percutaneous epidural lead (Model 3890, Medtronic) to treat drug ...

During the study period, 400 patients were implanted with SCS devices. In this group, 37% of patients received devices from Boston Scientific, 27.5% from Medtronic, 22.5% from Nevro, 11.8% from Abbott ...

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G, 770G ...